These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23291965)

  • 1. Positive correlation between the dysregulation of transforming growth factor-β1 and aneurysmal pathological changes in patients with Marfan syndrome.
    Kim KL; Yang JH; Song SH; Kim JY; Jang SY; Kim JM; Kim JA; Sung KI; Kim YW; Suh YL; Suh W; Kim DK
    Circ J; 2013; 77(4):952-8. PubMed ID: 23291965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway.
    Gomez D; Al Haj Zen A; Borges LF; Philippe M; Gutierrez PS; Jondeau G; Michel JB; Vranckx R
    J Pathol; 2009 May; 218(1):131-42. PubMed ID: 19224541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.
    Nataatmadja M; West J; West M
    Circulation; 2006 Jul; 114(1 Suppl):I371-7. PubMed ID: 16820603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating transforming growth factor-beta in Marfan syndrome.
    Matt P; Schoenhoff F; Habashi J; Holm T; Van Erp C; Loch D; Carlson OD; Griswold BF; Fu Q; De Backer J; Loeys B; Huso DL; McDonnell NB; Van Eyk JE; Dietz HC;
    Circulation; 2009 Aug; 120(6):526-32. PubMed ID: 19635970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics reveals Rictor as a noncanonical TGF-β signaling target during aneurysm progression in Marfan mice.
    Parker SJ; Stotland A; MacFarlane E; Wilson N; Orosco A; Venkatraman V; Madrid K; Gottlieb R; Dietz HC; Van Eyk JE
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1112-H1126. PubMed ID: 30004239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β mediates aortic smooth muscle cell senescence in Marfan syndrome.
    You W; Hong Y; He H; Huang X; Tao W; Liang X; Zhang Y; Li X
    Aging (Albany NY); 2019 May; 11(11):3574-3584. PubMed ID: 31147528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible extracardiac predictors of aortic dissection in Marfan syndrome.
    Agg B; Benke K; Szilveszter B; Pólos M; Daróczi L; Odler B; Nagy ZB; Tarr F; Merkely B; Szabolcs Z
    BMC Cardiovasc Disord; 2014 Apr; 14():47. PubMed ID: 24720641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
    Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms.
    Gomez D; Coyet A; Ollivier V; Jeunemaitre X; Jondeau G; Michel JB; Vranckx R
    Cardiovasc Res; 2011 Feb; 89(2):446-56. PubMed ID: 20829218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cystic disease in the Fbn1
    Hibender S; Wanga S; van der Made I; Vos M; Mulder BJ; Balm R; de Vries CJ; de Waard V
    Cardiovasc Pathol; 2019; 38():1-6. PubMed ID: 30359839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated expression levels of lysyl oxidases protect against aortic aneurysm progression in Marfan syndrome.
    Busnadiego O; Gorbenko Del Blanco D; González-Santamaría J; Habashi JP; Calderon JF; Sandoval P; Bedja D; Guinea-Viniegra J; Lopez-Cabrera M; Rosell-Garcia T; Snabel JM; Hanemaaijer R; Forteza A; Dietz HC; Egea G; Rodriguez-Pascual F
    J Mol Cell Cardiol; 2015 Aug; 85():48-57. PubMed ID: 25988230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for plasma transforming growth factor-beta and matrix metalloproteinases in aortic aneurysm surveillance in Marfan syndrome?
    Ahimastos AA; Aggarwal A; Savarirayan R; Dart AM; Kingwell BA
    Atherosclerosis; 2010 Mar; 209(1):211-4. PubMed ID: 19717156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting transforming growth factor-β signaling in aortopathies in Marfan syndrome.
    Sawaki D; Suzuki T
    Circ J; 2013; 77(4):898-9. PubMed ID: 23412757
    [No Abstract]   [Full Text] [Related]  

  • 16. Regional changes in elastic fiber organization and transforming growth factor β signaling in aortas from a mouse model of marfan syndrome.
    Howell DW; Popovic N; Metz RP; Wilson E
    Cell Tissue Res; 2014 Dec; 358(3):807-19. PubMed ID: 25238995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome.
    Franken R; den Hartog AW; de Waard V; Engele L; Radonic T; Lutter R; Timmermans J; Scholte AJ; van den Berg MP; Zwinderman AH; Groenink M; Mulder BJ
    Int J Cardiol; 2013 Oct; 168(3):2441-6. PubMed ID: 23582687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of transforming growth factor-β signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome.
    Hara H; Maemura S; Fujiwara T; Takeda N; Ishii S; Yagi H; Suzuki T; Harada M; Toko H; Kanaya T; Ijichi H; Moses HL; Takimoto E; Morita H; Akazawa H; Komuro I
    PLoS One; 2020; 15(11):e0239908. PubMed ID: 33175881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of oleic acid in the formation of the aortic aneurysm in Marfan syndrome patients.
    Soto ME; Iturriaga Hernández AV; Guarner Lans V; Zuñiga-Muñoz A; Aranda Fraustro A; Velázquez Espejel R; Pérez-Torres I
    Prostaglandins Other Lipid Mediat; 2016 Mar; 123():46-55. PubMed ID: 27163200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming Growth Factor-β1 Inhibits Pseudoaneurysm Formation After Aortic Patch Angioplasty.
    Bai H; Lee JS; Hu H; Wang T; Isaji T; Liu S; Guo J; Liu H; Wolf K; Ono S; Guo X; Yatsula B; Xing Y; Fahmy TM; Dardik A
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):195-205. PubMed ID: 29146747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.